Dexcom | DXCM - Sales Revenues

Dexcom reported $921M in Sales Revenues for its fiscal quarter ending in March of 2024.

Sales Change Date
Abbott USD 9.96B 281M Mar/2024
Align Technology USD 997.4M 40.67M Mar/2024
AtriCure USD 106.54M 8.25M Dec/2023
Avanos Medical USD 173.3M 2M Dec/2023
Baxter International USD 3.88B 177M Dec/2023
Becton, Dickinson and Co. USD 4.71B 381M Dec/2023
Boston Scientific USD 3.86B 135M Mar/2024
Cooper Companies USD 931.6M 4.5M Dec/2023
Dexcom USD 921M 113.5M Mar/2024
Edwards Lifesciences USD 1.6B 65.9M Mar/2024
Globus Medical USD 616.53M 232.9M Dec/2023
Hologic USD 1.01B 67.8M Dec/2023
Insulet USD 509.8M 77.1M Dec/2023
Integra LifeSciences USD 397.04M 14.62M Dec/2023
J&J USD 21.38B 15M Mar/2024
Masimo USD 548.9M 70M Dec/2023
Medtronic USD 8.09B 105M Dec/2023
Merit Medical Systems USD 324.52M 9.28M Dec/2023
Roche Holding CHF 28.94B 842M Dec/2023
Stryker USD 5.82B 906M Dec/2023
Tandem Diabetes Care USD 196.8M 11.17M Dec/2023
Teleflex USD 773.91M 27.52M Dec/2023
West Pharmaceutical Services USD 695.4M 36.6M Mar/2024
Zimmer Biomet Holdings USD 1.94B 186.5M Dec/2023